Upgrade to SI Premium - Free Trial

Halozyme Therapeutics (HALO) PT Raised to $95 at H.C. Wainwright

April 29, 2026 6:57 AM
(Updated - April 29, 2026 6:59 AM EDT)

H.C. Wainwright analyst Mitchell Kapoor raised the price target on Halozyme ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change